MPM Capital collects $400 mln for bioventure fund
MPM Capital has raised $400 million for its seventh venture fund BioVentures 2018. MPM focuses on companies that develop therapies "to treat severe unmet medical needs."
21 February 2019•3 mins read
MPM Capital has raised $400 million for its seventh venture fund BioVentures 2018. MPM focuses on companies that develop therapies "to treat severe unmet medical needs."
